Differential solubility of prions is associated in manifold phenotypes

Molecular and Cellular Neuroscience

Volumn 42, Issue 3, 2009, Pages 226-233

  Kuczius, Thorsten ^a   Karch, Helge ^a   Groschup, Martin H ^b  

^a UNIVERSITY HOSPITAL MÜNSTER   (Germany)

^b FEDERAL RESEARCH INSTITUTE FOR ANIMAL HEALTH   (Germany)

Author keywords

Glycotyping; Isoform; Phenotype; Prion; Protein; Solubility

Indexed keywords

GLYCOPROTEIN; ISOPROTEIN; PRION PROTEIN;

ANIMAL TISSUE; ARTICLE; BRAIN HOMOGENATE; CATTLE DISEASE; CONTROLLED STUDY; HUMAN; HUMAN TISSUE; INFECTION CONTROL; NONHUMAN; PHENOTYPE; PRION DISEASE; PRIORITY JOURNAL; PROTEIN DETERMINATION; PROTEIN FOLDING; PROTEIN MODIFICATION; SHEEP DISEASE; SOLUBILITY;

ANIMALS; BRAIN; BRAIN CHEMISTRY; CATTLE; DETERGENTS; HUMANS; PHENOTYPE; PRION DISEASES; PROTEIN ISOFORMS; PRPC PROTEINS; PRPSC PROTEINS; SHEEP; SODIUM DODECYL SULFATE; SOLUBILITY;

BOS; OVIS ARIES;

EID: 69249225563     PISSN: 10447431     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.mcn.2009.07.004     Document Type: Article

References (49)

1. Bendheim P.E., Brown H.R., Rudelli R.D., Scala L.J., Goller N.L., Wen G.Y., Kascsak R.J., Cashman N.R., and Bolton D.C. Nearly ubiquitous tissue distribution of the scrapie agent precursor protein. Neurology 42 (1992) 149-156
2. Benestad S.L., Sarradin P., Thu B., Schonheit J., Tranulis M.A., and Bratberg B. Cases of scrapie with unusual features in Norway and designation of a new type Nor98. Vet. Rec. 153 (2003) 202-208
3. Beringue V., Mallinson G., Kaisar M., Tayebi M., Sattar Z., Jackson G., Anstee D., Collinge J., and Hawke S. Regional heterogeneity of cellular prion protein isoforms in the mouse brain. Brain 126 (2003) 2065-2073
4. Buschmann A., Biacabe A.G., Ziegler U., Bencsik A., Madec J.Y., Erhardt G., Luhken G., Baron T., and Groschup M.H. Atypical scrapie cases in Germany and France are identified by discrepant reaction patterns in BSE rapid tests. J. Virol. Meth. 117 (2004) 27-36
5. Casalone C., Zanusso G., Acutis P., Ferrari S., Cappucci L., Tagliavini F., Monaco S., and Caramelli M. Identification of a second bovine amyloidotic spongiform encephalopathy: molecular similarities with sporadic Creutzfeldt-Jakob disease. Proc. Natl. Acad. Sci. U. S. A. 101 (2004) 3065-3070
6. Caughey B. Scrapie associated PrP accumulation and its prevention: insights from cell culture. Br. Med. Bull. 49 (1993) 860-872
7. Chen S.G., Teplow D.B., Parchi P., Teller J.K., Gambetti P., and Autilio-Gambetti L. Truncated forms of the human prion protein in normal brain and in prion diseases. J. Biol. Chem. 270 (1995) 19173-19780
8. Collinge J., Sidle K.C., Meads J., Ironside J., and Hill A.F. Molecular analysis of prion strain variation and the aetiology of 'new variant' CJD. Nature 383 (1996) 685-690
9. c glycoform heterogeneity as a function of brain region: implications for selective targeting of neurons by prion strains. J. Neuropathol. Exp. Neurol. 58 (1999) 1000-1009
10. DeArmond S.J., Sánchez H., Yehiely F., Qiu Y., Ninchak-Casey A., Daggett V., Camerino A.P., Cayetano J., Rogers M., Groth D., Torchia M., Tremblay P., Scott M.R., Cohen F.E., and Prusiner S.B. Selective neuronal targeting in prion disease. Neuron 19 (1997) 1337-1348
11. Demart S., Fournier J.G., Creminon C., Frobert Y., Lamoury F., Marce D., Lasmezas C., Dormont D., Grassi J., and Deslys J.P. New insight into abnormal prion protein using monoclonal antibodies. Biochem. Biophys. Res. Commun. 265 (1999) 652-657
12. Donne D.G., Viles J.H., Groth D., Mehlhorn I., James T.L., Cohen F.E., Prusiner S.B., Wright P.E., and Dyson H.J. Structure of the recombinant full-length hamster prion protein PrP(29-231): the N terminus is highly flexible. Proc. Natl. Acad. Sci. U. S. A. 94 (1997) 13452-13457
13. Endo T., Groth D., Prusiner S.B., and Kobata A. Diversity of oligosaccharide structures linked to asparagines of the scrapie prion protein. Biochemistry 28 (1989) 8380-8388
14. Gambetti P., Kong Q., Zou W., Parchi P., and Chen S.G. Sporadic and familial CJD: classification and characterisation. Br. Med. Bull. 66 (2003) 213-239
15. Groschup M.H., Kuczius T., Junghans F., Sweeney T., Bodemer W., and Buschmann A. Characterization of BSE and scrapie strains/isolates. Arch. Virol. Suppl. 16 (2000) 217-226
16. Head M.W., Bunn T.J., Bishop M.T., McLoughlin V., Lowrie S., McKimmie C.S., Williams M.C., McCardle L., MacKenzie J., Knight R., Will R.G., and Ironside J.W. Prion protein heterogeneity in sporadic but not variant Creutzfeldt-Jakob disease: UK cases 1991-2002. Ann. Neurol. 55 (2004) 851-859
17. Hill A.F., Joiner S., Wadsworth J.D., Sidle K.C., Bell J.E., Budka H., Ironside J.W., and Collinge J. Molecular classification of sporadic Creutzfeldt-Jakob disease. Brain 126 (2003) 1333-1346
18. Hundt C., Peyrin J.M., Haik S., Gauczynski S., Leucht C., Rieger R., Riley M.L., Deslys J.P., Dormont D., Lasmezas C.I., and Weiss S. Identification of interaction domains of the prion protein with its 37-kDa/67-kDa laminin receptor. EMBO J. 20 (2001) 5876-5886
19. Jackson G.S., Murray I., Hosszu L.L., Gibbs N., Waltho J.P., Clarke A.R., and Collinge J. Location and properties of metalbinding sites on the human prion protein. Proc. Natl. Acad. Sci. U. S. A. 98 (2001) 8531-8535
20. Jimenez-Huete A., Lievens P.M., Vidal R., Piccardo P., Ghetti B., Tagliavini F., Frangione B., and Prelli F. Endogenous proteolytic cleavage of normal and diseaseassociated isoforms of the human prion protein in neural and non-neural tissues. Am. J. Pathol. 153 (1998) 1561-1572
21. Kanaani J., Prusiner S.B., Diacovo J., Baekkeskov S., and Legname G. Recombinant prion protein induces rapid polarization and development of synapses in embryonic rat hippocampal neurons in vitro. J. Neurochem. 95 (2005) 1373-1386
22. Krebs B., Dorner-Ciossek C., Schmalzbauer R., Vassallo N., Herms J., and Kretzschmar H.A. Prion protein induced signaling cascades in monocytes. Biochem. Biophys. Res. Commun. 340 (2006) 13-22
23. Kretzschmar H.A., Prusiner S.B., Stowring L.E., and DeArmond S.J. Scrapie prion proteins are synthesized in neurons. Am. J. Pathol. 122 (1986) 1-5
24. Kuczius T., Haist I., and Groschup M.H. Molecular analysis of bovine spongiform encephalopathy and scrapie strain variation. J. Infect. Dis. 178 (1998) 693-699
25. C) obtained from human, sheep, cattle and mouse. FEBS J. 274 (2007) 1492-1502
26. Kuczius T., Koch R., Keyvani K., Karch H., Grassi J., and Groschup M.H. Regional and phenotype heterogeneity of cellular prion proteins in the human brain. Eur. J. Neurosci. 25 (2007) 2649-2655
27. Sc by Western blotting. Neurochem. Int. 50 (2007) 102-108
28. Laffont-Proust I., Hassig R., Haik S., Simon S., Grassi J., Fonta C., Faucheux B.A., and Moya K.L. Truncated PrPc in mammalian brain: interspecies variation and location in membrane rafts. Biol. Chem. 387 (2006) 297-300
29. Levavasseur E., Laffont-Proust I., Morain E., Faucheux B.A., Privat N., Peoc'h K., Sazdovitch V., Brandel J.P., Hauw J.J., and Haïk S. Regulating factors of PrP glycosylation in Creutzfeldt-Jakob disease-implications for the dissemination and the diagnosis of human prion strains. PLoS ONE 3 (2008) e2786
30. Linden R., Martins V.R., Prado M.A., Cammarota M., Izquierdo I., and Brentani R.R. Physiology of the prion protein. Physiol. Rev. 88 (2008) 673-728
31. Mouillet-Richard S., Ermonval M., Chebassier C., Laplanche J.L., Lehmann S., Launay J.M., and Kellermann O. Signal transduction through prion protein. Science 289 (2000) 1925-1928
32. Mouillet-Richard S., Schneider B., Pradines E., Pietri M., Ermonval M., Grassi J., Richards J.G., Mutel V., Launay J.M., and Kellermann O. Cellular prion protein signaling in serotonergic neuronal cells. Ann. N.Y. Acad. Sci. 1096 (2007) 106-119
33. Pan T., Li R., Wong B.S., Liu T., Gambetti P., and Sy M.S. Heterogeneity of normal prion protein in two-dimensional immunoblot: presence of various glycosylated and truncated forms. J. Neurochem. 81 (2002) 1092-1101
34. Sc types in individuals with Creutzfeldt-Jakob disease. Lancet Neurol. 4 (2005) 805-814
35. Prusiner S.B. Prions. Proc. Natl. Acad. Sci. U. S. A. 95 (1998) 13363-13383
36. Riek R., Hornemann S., Wider G., Glockshuber R., and Wüthrich K. NMR characterization of the full-length recombinant murine prion protein, mPrP(23-231). FEBS Lett. 413 (1997) 282-288
37. Rudd P.M., Endo T., Colominas C., Groth D., Wheeler S.F., Harvey D.J., Wormald M.R., Serban H., Prusiner S.B., Kobata A., and Dwek R.A. Glycosylation differences between the normal and pathogenic prion protein isoforms. Proc. Natl. Acad. Sci. U. S. A. 96 (1999) 13044-13049
38. Sc molecules with different conformations. Nat. Med. 4 (1998) 1157-1165
39. Schmitt-Ulms G., Legname G., Baldwin M.A., Ball H.L., Bradon N., Bosque P.J., Crossin K.L., Edelman G.M., DeArmond S.J., Cohen F.E., and Prusiner S.B. Binding of neural cell adhesion molecules (N-CAMs) to the cellular prion protein. J. Mol. Biol. 314 (2001) 1209-1225
40. Schneider B., Mutel V., Pietri M., Ermonval M., Mouillet-Richard S., and Kellermann O. NADPH oxidase and extracellular regulated kinases 1/2 are targets of prion protein signaling in neuronal and nonneuronal cells. Proc. Natl. Acad. Sci. U. S. A. 100 (2003) 13326-13331
41. Somerville R.A., Chong A., Mulqueen O.U., Birkett C.R., Wood S.C., and Hope J. Biochemical typing of scrapie strains. Nature 386 (1997) 564
42. Soto C., Saborio G.P., and Anderes L. Cyclic amplification of protein misfolding: application to prion-related disorders and beyond. Trends Neurosci. 25 (2002) 390-394
43. Tuzi N.L., Cancellotti E., Baybutt H., Blackford L., Bradford B., Plinston C., Coghill A., Hart P., Piccardo P., Barron R.M., and Manson J.C. Host PrP glycosylation: a major factor determining the outcome of prion infection. PLoS Biol. 6 (2008) e100
44. Vincent B., Paitel E., Saftig P., Frobert Y., Hartmann D., De Strooper B., Grassi J., Lopez-Perez E., and Checler F. The disintegrins ADAM10 and TACE contribute to the constitutive and phorbol ester-regulated normal cleavage of the cellular prion protein. J. Biol. Chem. 276 (2001) 37743-37746
45. Vorberg I., and Priola S.A. Molecular basis of scrapie strain glycoform variation. J. Biol. Chem. 277 (2002) 36775-36781
46. Wadsworth J.D., Joiner S., Hill A.F., Campbell T.A., Desbruslais M., Luthert P.J., and Collinge J. Tissue distribution of protease resistant prion protein in variant Creutzfeldt-Jakob disease using a highly sensitive immunoblotting assay. Lancet 358 (2001) 171-180
47. Yuan J., Xiao X., McGeehan J., Dong Z., Cali I., Fujioka H., Kong Q., Kneale G., Gambetti P., and Zou W.Q. Insoluble aggregates and protease-resistant conformers of prion protein in uninfected human brains. J. Biol. Chem. 281 (2006) 34848-34858
48. Yull H.M., Ritchie D.L., Langeveld J.P., van Zijderveld F.G., Bruce M.E., Ironside J.W., and Head M.W. Detection of type 1 prion protein in variant Creutzfeldt-Jakob disease. Am. J. Pathol. 168 (2006) 151-157
49. Zahn R., Liu A., Luhrs T., Riek R., von Schroetter C., Lopez Garcia F., Billeter M., Calzolai L., Wider G., and Wuthrich K. NMR solution structure of the human prion protein. Proc. Natl. Acad. Sci. U. S. A. 97 (2000) 145-150